{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:31:00Z","timestamp":1790134260300,"version":"4.0.1"},"reference-count":281,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.lfs.2024.122858","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T04:53:18Z","timestamp":1719031998000},"page":"122858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Stem cell and exosome therapies for regenerating damaged myocardium in heart failure"],"prefix":"10.1016","volume":"351","author":[{"given":"Roghayeh","family":"Yahyazadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vafa","family":"Baradaran Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid Reza","family":"Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0005","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/biof.1874","article-title":"Three months of combination therapy with nano-curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary artery disease: evidence of a randomized, double-blinded, placebo-controlled clinical trial","volume":"49","author":"Dastani","year":"2023","journal-title":"BioFactors"},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb0010","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s10787-021-00865-0","article-title":"Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial","volume":"29","author":"Gholoobi","year":"2021","journal-title":"Inflammopharmacology"},{"issue":"6","key":"10.1016\/j.lfs.2024.122858_bb0015","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.pharep.2019.07.007","article-title":"Crocin protects cardiomyocytes against LPS-induced inflammation","volume":"71","author":"Baradaran Rahim","year":"2019","journal-title":"Pharmacol. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2024.122858_bb0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jiac.2022.11.007","article-title":"Increasing cardiac troponin-I level as a cardiac injury index correlates with in-hospital mortality and biofactors in severe hospitalised COVID-19 patients","volume":"29","author":"Bayaz","year":"2023","journal-title":"J. Infect. Chemother."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11936-013-0283-0","article-title":"Medical management of patients with continuous-flow left ventricular assist devices","volume":"16","author":"Devore","year":"2014","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb0030","first-page":"1115","article-title":"Relationship between New York functional class and duke activity status index with the severity of mitral valve stenosis and echocardiographic parameters: is left atrial strain a better predictor?","volume":"40","author":"Bigdelu","year":"2024","journal-title":"Int. J. Card. Imaging"},{"issue":"8","key":"10.1016\/j.lfs.2024.122858_bb0035","first-page":"1120","article-title":"Adult heart transplant: indications and outcomes","volume":"6","author":"Alraies","year":"2014","journal-title":"J. Thorac. Dis."},{"issue":"6","key":"10.1016\/j.lfs.2024.122858_bb0040","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1159\/000492704","article-title":"Stem cell therapy in heart diseases - cell types, mechanisms and improvement strategies","volume":"48","author":"M\u00fcller","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","article-title":"Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial","volume":"311","author":"Heldman","year":"2014","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0050","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jacc.2013.08.724","article-title":"Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-derived aUtologous stem CElls to reverse ventricUlar dySfunction)","volume":"63","author":"Malliaras","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"15","key":"10.1016\/j.lfs.2024.122858_bb0055","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/jama.2013.3527","article-title":"Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial","volume":"309","author":"Assmus","year":"2013","journal-title":"Jama"},{"issue":"19","key":"10.1016\/j.lfs.2024.122858_bb0060","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/eurheartj\/ehu117","article-title":"Regenerative heart failure therapy headed for optimization","volume":"35","author":"Terzic","year":"2014","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0021-9258(17)34997-9","article-title":"The biological significance of the thromboplastic protein of blood","volume":"166","author":"Chargaff","year":"1946","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.122858_bb0070","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-013-1084-8","article-title":"Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies","volume":"113","author":"Akers","year":"2013","journal-title":"J. Neuro-Oncol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.lfs.2024.122858_bb0085","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v3.26913","article-title":"Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles","volume":"3","author":"L\u00f6tvall","year":"2014","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0090","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J Extracell Vesicles"},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0095","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ceb.2008.04.001","article-title":"Multivesicular bodies: co-ordinated progression to maturity","volume":"20","author":"Woodman","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"issue":"9","key":"10.1016\/j.lfs.2024.122858_bb0100","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrm2755","article-title":"Pathways and mechanisms of endocytic recycling","volume":"10","author":"Grant","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2024.122858_bb0105","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.biopha.2017.07.084","article-title":"A comprehensive review on the potential therapeutic benefits of phosphodiesterase inhibitors on cardiovascular diseases","volume":"94","author":"Shafiee-Nick","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.lfs.2024.122858_bb0110","doi-asserted-by":"crossref","first-page":"9997","DOI":"10.1074\/jbc.M309992200","article-title":"Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function","volume":"279","author":"Megha; London, E.","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0115","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1083\/jcb.149.4.901","article-title":"Distinct membrane domains on endosomes in the recycling pathway visualized by multicolor imaging of Rab4, Rab5, and Rab11","volume":"149","author":"S\u00f6nnichsen","year":"2000","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0120","doi-asserted-by":"crossref","first-page":"3.22. 21","DOI":"10.1002\/0471143030.cb0322s30","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids","volume":"30","author":"Th\u00e9ry","year":"2006","journal-title":"Curr. Protoc. Cell Biol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0125","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.devcel.2011.08.019","article-title":"The tetraspanin CD63 regulates ESCRT-independent and-dependent endosomal sorting during melanogenesis","volume":"21","author":"Van Niel","year":"2011","journal-title":"Dev. Cell"},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0130","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3390\/ijms24021337","article-title":"The machinery of exosomes: biogenesis, release, and uptake","volume":"24","author":"Krylova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0135","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v3.24641","article-title":"Routes and mechanisms of extracellular vesicle uptake","volume":"3","author":"Mulcahy","year":"2014","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0140","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ijc.30669","article-title":"The role of exosomes and miRNAs in drug-resistance of cancer cells","volume":"141","author":"Bach","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2024.122858_bb0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/bs.acr.2018.05.004","article-title":"Ceramide and exosomes: a novel target in cancer biology and therapy","volume":"140","author":"Elsherbini","year":"2018","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.lfs.2024.122858_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-0991-5","article-title":"Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance","volume":"18","author":"Mashouri","year":"2019","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.lfs.2024.122858_bb0155","doi-asserted-by":"crossref","first-page":"H1162","DOI":"10.1152\/ajpheart.00075.2020","article-title":"Exosomes in disease and regeneration: biological functions, diagnostics, and beneficial effects","volume":"319","author":"Lin","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2024.122858_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111148","article-title":"Circulating exosomes in cardiovascular disease: novel carriers of biological information","volume":"135","author":"Liu","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.lfs.2024.122858_bb0165","doi-asserted-by":"crossref","first-page":"H3052","DOI":"10.1152\/ajpheart.01355.2006","article-title":"HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway","volume":"292","author":"Gupta","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.lfs.2024.122858_bb0170","doi-asserted-by":"crossref","first-page":"H954","DOI":"10.1152\/ajpheart.00835.2012","article-title":"Cardiac myocyte exosomes: stability, HSP60, and proteomics","volume":"304","author":"Malik","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0175","doi-asserted-by":"crossref","first-page":"H733","DOI":"10.1152\/ajpheart.00100.2018","article-title":"Emerging roles of extracellular vesicles in cardiac repair and rejuvenation","volume":"315","author":"Alibhai","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2024.122858_bb0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-981-10-4397-0_4","article-title":"Exosomes as diagnostic biomarkers in cardiovascular diseases","volume":"998","author":"Jansen","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb0185","first-page":"4350","article-title":"Exosomes derived from cardiomyocytes promote cardiac fibrosis via myocyte-fibroblast cross-talk","volume":"10","author":"Yang","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"11","key":"10.1016\/j.lfs.2024.122858_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112933","article-title":"Roles of exosomes in cardiac fibroblast activation and fibrosis","volume":"10","author":"Hohn","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.lfs.2024.122858_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138849","article-title":"Glucose starvation in cardiomyocytes enhances exosome secretion and promotes angiogenesis in endothelial cells","volume":"10","author":"Garcia","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.lfs.2024.122858_bb0200","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1111\/jcmm.12589","article-title":"Cardiosome mediated regulation of MMP9 in diabetic heart: role of mir29b and mir455 in exercise","volume":"19","author":"Chaturvedi","year":"2015","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.lfs.2024.122858_bb0205","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1139\/y11-131","article-title":"Ablation of MMP9 induces survival and differentiation of cardiac stem cells into cardiomyocytes in the heart of diabetics: a role of extracellular matrix","volume":"90","author":"Mishra","year":"2012","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb0210","doi-asserted-by":"crossref","first-page":"21796","DOI":"10.1002\/jcp.28942","article-title":"Circulating exosomal miRNAs in cardiovascular disease pathogenesis: new emerging hopes","volume":"234","author":"Aghabozorgi","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.lfs.2024.122858_bb0215","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/dna.2016.3496","article-title":"Characteristics and roles of exosomes in cardiovascular disease","volume":"36","author":"Zhang","year":"2017","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.lfs.2024.122858_bb0220","first-page":"212","article-title":"Niosome as a promising tool for increasing the effectiveness of anti-inflammatory compounds","volume":"23","author":"Fadaei","year":"2024","journal-title":"EXCLI J."},{"key":"10.1016\/j.lfs.2024.122858_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115263","article-title":"Metformin beyond an anti-diabetic agent: a comprehensive and mechanistic review on its effects against natural and chemical toxins","volume":"165","author":"Malaekeh-Nikouei","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb0230","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI70577","article-title":"Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy","volume":"124","author":"Bang","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"23","key":"10.1016\/j.lfs.2024.122858_bb0235","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.jacc.2012.02.033","article-title":"Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease","volume":"59","author":"Xu","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.lfs.2024.122858_bb0240","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1161\/CIRCULATIONAHA.112.093906","article-title":"Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity","volume":"126","author":"Jakob","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.lfs.2024.122858_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023114","article-title":"microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4","volume":"6","author":"Tano","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0250","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12964-023-01227-9","article-title":"Advances in the study of exosomes derived from mesenchymal stem cells and cardiac cells for the treatment of myocardial infarction","volume":"21","author":"Liu","year":"2023","journal-title":"Cell Communication and Signaling"},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0255","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.devcel.2022.01.012","article-title":"Heart regeneration: 20 years of progress and renewed optimism","volume":"57","author":"Garbern","year":"2022","journal-title":"Dev. Cell"},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0260","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/emmm.201201737","article-title":"Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart","volume":"5","author":"Malliaras","year":"2013","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0265","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood-2012-01-407106","article-title":"AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics","volume":"121","author":"Mocharla","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0270","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.devcel.2008.07.008","article-title":"miR-126 regulates angiogenic signaling and vascular integrity","volume":"15","author":"Fish","year":"2008","journal-title":"Dev. Cell"},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb0275","doi-asserted-by":"crossref","first-page":"H928","DOI":"10.1152\/ajpheart.00602.2017","article-title":"Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure","volume":"314","author":"Tian","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.lfs.2024.122858_bb0280","doi-asserted-by":"crossref","first-page":"H1253","DOI":"10.1152\/ajpheart.00096.2018","article-title":"cROSsing the cardiac MIRe: fibroblast-cardiomyocyte ex(o)press","volume":"314","author":"Abreu","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"15","key":"10.1016\/j.lfs.2024.122858_bb0285","first-page":"2435","article-title":"Mesenchymal stem cell-derived exosome transplantation for ischemic heart disease","volume":"27","author":"Liu","year":"2023","journal-title":"Chinese Journal of Tissue Engineering Research"},{"key":"10.1016\/j.lfs.2024.122858_bb0290","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-981-10-4397-0_12","article-title":"Therapeutic effects of mesenchymal stem cell-derived exosomes in cardiovascular disease","volume":"998","author":"Suzuki","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2024.122858_bb0295","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.yjmcc.2022.04.020","article-title":"Minimally invasive delivery of a hydrogel-based exosome patch to prevent heart failure","volume":"169","author":"Cheng","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0300","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bja.2022.08.040","article-title":"Plasma exosomes generated by ischaemic preconditioning are cardioprotective in a rat heart failure model","volume":"130","author":"Luo","year":"2023","journal-title":"Br. J. Anaesth."},{"issue":"3","key":"10.1016\/j.lfs.2024.122858_bb0305","article-title":"Plasma-derived exosomes implement miR-126-associated regulation of cytokines secretion in PBMCs of CHF patients in vitro","volume":"93","author":"Natrus","year":"2022","journal-title":"Acta Biomed"},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0310","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7150\/thno.38198","article-title":"Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium","volume":"10","author":"Wan","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2024.122858_bb0315","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jconrel.2022.12.027","article-title":"Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications","volume":"353","author":"Mondal","year":"2023","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0320","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/JCN.0b013e318197a6a5","article-title":"Introduction to stem cell therapy","volume":"24","author":"Biehl","year":"2009","journal-title":"J. Cardiovasc. Nurs."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0325","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41569-019-0327-6","article-title":"Stem cell therapy improves heart function by triggering an acute immune response","volume":"17","author":"Huynh","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.06.003","article-title":"Stem cell therapy in heart failure: where do we stand today?","volume":"1866","author":"Nair","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"7","key":"10.1016\/j.lfs.2024.122858_bb0335","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/clc.20922","article-title":"Heart failure after myocardial infarction: clinical implications and treatment","volume":"34","author":"Minicucci","year":"2011","journal-title":"Clin. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0340","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-62607-w","article-title":"Evaluation of short and mid-term clinical outcomes in patients with aortic coarctation treated with self-expandable stents","volume":"14","author":"Mohammadzadeh Shabestari","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0345","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.stem.2011.12.013","article-title":"Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming","volume":"10","author":"Burridge","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0350","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.scr.2015.08.002","article-title":"Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells","volume":"15","author":"Chen","year":"2015","journal-title":"Stem Cell Res."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0355","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s12015-021-10183-1","article-title":"Correction to: cardiac differentiation of mesenchymal stem cells: impact of biological and chemical inducers","volume":"17","author":"Ramesh","year":"2021","journal-title":"Stem Cell Rev. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0360","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13287-020-01602-0","article-title":"Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts","volume":"11","author":"Guan","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"10.1016\/j.lfs.2024.122858_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072359","article-title":"Efficient cardiac differentiation of human amniotic fluid-derived stem cells into induced pluripotent stem cells and their potential immune privilege","volume":"21","author":"Fang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.lfs.2024.122858_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810314","article-title":"Cell-based and selected cell-free therapies for myocardial infarction: how do they compare to the current treatment options?","volume":"23","author":"Cs\u00f6b\u00f6nyeiov\u00e1","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0375","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2024.122858_bb0380","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fcell.2016.00134","article-title":"Describing the stem cell potency: the various methods of functional assessment and in silico diagnostics","volume":"4","author":"Singh","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0385","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4252\/wjsc.v13.i4.236","article-title":"Stem cell therapy for heart failure: medical breakthrough, or dead end?","volume":"13","author":"Rheault-Henry","year":"2021","journal-title":"World J Stem Cells"},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0390","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/bmb\/ldw059","article-title":"Stem cell therapy for ischemic heart diseases","volume":"121","author":"Yu","year":"2017","journal-title":"Br. Med. Bull."},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb0395","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.3727\/096368914X685799","article-title":"Functional and electrical integration of induced pluripotent stem cell-derived cardiomyocytes in a myocardial infarction rat heart","volume":"24","author":"Higuchi","year":"2015","journal-title":"Cell Transplant."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0400","doi-asserted-by":"crossref","DOI":"10.1242\/bio.053348","article-title":"Single-cell sequencing reveals the potential oncogenic expression atlas of human iPSC-derived cardiomyocytes","volume":"10","author":"Ou","year":"2021","journal-title":"Biol Open"},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0405","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12265-011-9330-y","article-title":"Using biomaterials to improve the efficacy of cell therapy following acute myocardial infarction","volume":"5","author":"Traverse","year":"2012","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb0410","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1253\/circj.CJ-19-0567","article-title":"Function follows form - a review of cardiac cell therapy","volume":"83","author":"Nakamura","year":"2019","journal-title":"Circ. J."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0415","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cveq.2011.04.003","article-title":"Embryonic stem cells and iPS cells: sources and characteristics","volume":"27","author":"Hackett","year":"2011","journal-title":"Vet. Clin. North Am. Equine Pract."},{"issue":"3","key":"10.1016\/j.lfs.2024.122858_bb0420","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI200112131","article-title":"Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes","volume":"108","author":"Kehat","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.lfs.2024.122858_bb0425","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCRESAHA.115.306985","article-title":"Human engineered heart muscles engraft and survive long term in a rodent myocardial infarction model","volume":"117","author":"Riegler","year":"2015","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.lfs.2024.122858_bb0430","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/nprot.2015.089","article-title":"Cardiac differentiation of human pluripotent stem cells in scalable suspension culture","volume":"10","author":"Kempf","year":"2015","journal-title":"Nat. Protoc."},{"issue":"363","key":"10.1016\/j.lfs.2024.122858_bb0435","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf8781","article-title":"Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells","volume":"8","author":"Weinberger","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb0440","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.stemcr.2019.04.005","article-title":"Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular Tachyarrhythmias","volume":"12","author":"Romagnuolo","year":"2019","journal-title":"Stem Cell Rep."},{"issue":"7","key":"10.1016\/j.lfs.2024.122858_bb0445","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt.4162","article-title":"Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates","volume":"36","author":"Liu","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"21","key":"10.1016\/j.lfs.2024.122858_bb0450","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jacc.2021.09.019","article-title":"Basic and translational research in cardiac repair and regeneration: JACC state-of-the-art review","volume":"78","author":"Zhang","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0455","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jacc.2017.11.047","article-title":"Transplantation of human embryonic stem cell-derived cardiovascular progenitors for severe ischemic left ventricular dysfunction","volume":"71","author":"Menasch\u00e9","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4252\/wjsc.v14.i1.1","article-title":"Cardiac stem cells: current knowledge and future prospects","volume":"14","author":"Mehanna","year":"2022","journal-title":"World journal of stem cells"},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb0465","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1634\/stemcells.2006-0466","article-title":"Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach","volume":"25","author":"Sartiani","year":"2007","journal-title":"Stem Cells"},{"issue":"21","key":"10.1016\/j.lfs.2024.122858_bb0470","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/01.CIR.0000068356.38592.68","article-title":"Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells","volume":"107","author":"Mummery","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0475","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bjp.0707619","article-title":"beta(1)- and beta(2)-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart","volume":"153","author":"Brito-Martins","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0480","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/14653249.2011.623690","article-title":"Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition","volume":"14","author":"Yeghiazarians","year":"2012","journal-title":"Cytotherapy"},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb0485","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1096\/fj.02-0072com","article-title":"Stem cell differentiation requires a paracrine pathway in the heart","volume":"16","author":"Behfar","year":"2002","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.lfs.2024.122858_bb0490","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cvr\/cvp146","article-title":"Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium","volume":"83","author":"Smits","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2024.122858_bb0495","series-title":"Regenerative Medicine Special Feature: Interrogating Functional Integration between Injected Pluripotent Stem Cell-Derived Cells and Surrogate Cardiac Tissue: Proceedings of the National Academy of Science","author":"Song","year":"2010"},{"issue":"2\u20133","key":"10.1016\/j.lfs.2024.122858_bb0500","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.scr.2009.05.004","article-title":"Improvement of mouse cardiac function by hESC-derived cardiomyocytes correlates with vascularity but not graft size","volume":"3","author":"van Laake","year":"2009","journal-title":"Stem Cell Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0505","doi-asserted-by":"crossref","first-page":"H907","DOI":"10.1152\/ajpheart.00279.2008","article-title":"Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K\/Akt but not ERK pathway","volume":"295","author":"Singla","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0510","doi-asserted-by":"crossref","first-page":"H1726","DOI":"10.1152\/ajpheart.00236.2008","article-title":"Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions","volume":"295","author":"Crisostomo","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0515","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI40120","article-title":"A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates","volume":"120","author":"Blin","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"7504","key":"10.1016\/j.lfs.2024.122858_bb0520","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature13233","article-title":"Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts","volume":"510","author":"Chong","year":"2014","journal-title":"Nature"},{"issue":"7415","key":"10.1016\/j.lfs.2024.122858_bb0525","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature11317","article-title":"Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts","volume":"489","author":"Shiba","year":"2012","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.lfs.2024.122858_bb0530","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.jacc.2007.07.054","article-title":"Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts","volume":"50","author":"Caspi","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0535","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.scr.2007.06.001","article-title":"Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction","volume":"1","author":"van Laake","year":"2007","journal-title":"Stem Cell Res."},{"issue":"9","key":"10.1016\/j.lfs.2024.122858_bb0540","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1327","article-title":"Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts","volume":"25","author":"Laflamme","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"10.1016\/j.lfs.2024.122858_bb0545","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41569-021-00625-1","article-title":"A phoenix rises from the ashes of cardiac cell therapy","volume":"18","author":"Marb\u00e1n","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb0550","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/sctm.18-0120","article-title":"Safety and efficacy of adult stem cell therapy for acute myocardial infarction and ischemic heart failure (SafeCell heart): a systematic review and Meta-analysis","volume":"7","author":"Lalu","year":"2018","journal-title":"Stem Cells Transl. Med."},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb0555","article-title":"Stem cell therapy for chronic ischaemic heart disease and congestive heart failure","volume":"12","author":"Fisher","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lfs.2024.122858_bb0560","article-title":"Dare to dream? Cell-based therapies for heart failure after DREAM-HF: review and roadmap for future clinical study","volume":"13","author":"Johnston","year":"2022","journal-title":"American Heart Journal Plus: Cardiology Research and Practice"},{"issue":"7","key":"10.1016\/j.lfs.2024.122858_bb0565","article-title":"Stem cell therapy for dilated cardiomyopathy","volume":"7","author":"Diaz-Navarro","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0570","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13287-016-0415-z","article-title":"Discrepancy between short-term and long-term effects of bone marrow-derived cell therapy in acute myocardial infarction: a systematic review and meta-analysis","volume":"7","author":"Lee","year":"2016","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0575","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1634\/stemcells.22-4-635","article-title":"Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells","volume":"22","author":"Urbach","year":"2004","journal-title":"Stem Cells"},{"issue":"7625","key":"10.1016\/j.lfs.2024.122858_bb0580","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nature19815","article-title":"Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts","volume":"538","author":"Shiba","year":"2016","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.lfs.2024.122858_bb0585","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1006\/jmcc.1998.0808","article-title":"Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy","volume":"30","author":"Poolman","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"11 Suppl 1","key":"10.1016\/j.lfs.2024.122858_bb0590","first-page":"S29","article-title":"Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model","volume":"126","author":"Kawamura","year":"2012","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb0595","doi-asserted-by":"crossref","first-page":"H2006","DOI":"10.1152\/ajpheart.00694.2011","article-title":"High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents","volume":"301","author":"Ma","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.lfs.2024.122858_bb0600","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/stem.1089","article-title":"Pluripotent stem cell-engineered cell sheets reassembled with defined cardiovascular populations ameliorate reduction in infarct heart function through cardiomyocyte-mediated neovascularization","volume":"30","author":"Masumoto","year":"2012","journal-title":"Stem Cells"},{"issue":"7","key":"10.1016\/j.lfs.2024.122858_bb0605","first-page":"613","article-title":"Maturation of cardiomyocytes derived from human pluripotent stem cells: current strategies and limitations","volume":"41","author":"Jiang","year":"2018","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb0610","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/1535370214565976","article-title":"Perspectives of induced pluripotent stem cells for cardiovascular system regeneration","volume":"240","author":"Cs\u00f6b\u00f6nyeiov\u00e1","year":"2015","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0615","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccep.2010.10.012","article-title":"Overview of basic mechanisms of cardiac arrhythmia","volume":"3","author":"Antzelevitch","year":"2011","journal-title":"Card Electrophysiol Clin"},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0620","doi-asserted-by":"crossref","first-page":"8824","DOI":"10.1038\/s41598-017-08869-z","article-title":"Enhanced therapeutic effects of human iPS cell derived-cardiomyocyte by combined cell-sheets with omental flap technique in porcine ischemic cardiomyopathy model","volume":"7","author":"Kawamura","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.lfs.2024.122858_bb0625","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.healun.2021.04.010","article-title":"Therapeutic efficacy of large aligned cardiac tissue derived from induced pluripotent stem cell in a porcine ischemic cardiomyopathy model","volume":"40","author":"Suzuki","year":"2021","journal-title":"J. Heart Lung Transplant."},{"issue":"3","key":"10.1016\/j.lfs.2024.122858_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174115","article-title":"Characterization of stromal vascular fraction and adipose stem cells from subcutaneous, preperitoneal and visceral morbidly obese human adipose tissue depots","volume":"12","author":"Silva","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0635","first-page":"125","article-title":"Adipose tissue-derived stem cells: immunomodulatory effects and therapeutic potential","volume":"35","author":"Al-Ghadban","year":"2020","journal-title":"Physiology (Bethesda)"},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb0640","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.trsl.2014.12.005","article-title":"Adipose-derived stem cell sheet transplantation therapy in a porcine model of chronic heart failure","volume":"165","author":"Ishida","year":"2015","journal-title":"Transl. Res."},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb0645","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","article-title":"Human adipose tissue is a source of multipotent stem cells","volume":"13","author":"Zuk","year":"2002","journal-title":"Mol. Biol. Cell"},{"issue":"9","key":"10.1016\/j.lfs.2024.122858_bb0650","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/01.RES.0000265074.83288.09","article-title":"Adipose-derived stem cells for regenerative medicine","volume":"100","author":"Gimble","year":"2007","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.lfs.2024.122858_bb0655","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/ATVBAHA.109.187179","article-title":"Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair","volume":"29","author":"Madonna","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.lfs.2024.122858_bb0660","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3727\/096368907783338190","article-title":"Adipose-derived cells","volume":"16","author":"Meliga","year":"2007","journal-title":"Cell Transplant."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0665","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nm1391","article-title":"Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction","volume":"12","author":"Miyahara","year":"2006","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0670","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCULATIONAHA.107.702993","article-title":"Stunning, hibernation, and assessment of myocardial viability","volume":"117","author":"Camici","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb0675","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.CIR.0000114522.38265.61","article-title":"Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives","volume":"109","author":"Planat-Benard","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2024.122858_bb0680","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/812693","article-title":"Adipose-derived mesenchymal stromal\/stem cells: tissue localization, characterization, and heterogeneity","volume":"2012","author":"Baer","year":"2012","journal-title":"Stem Cells Int."},{"issue":"21","key":"10.1016\/j.lfs.2024.122858_bb0685","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/eurheartj\/ehm426","article-title":"Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction","volume":"28","author":"Valina","year":"2007","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.lfs.2024.122858_bb0690","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/cvr\/cvr099","article-title":"Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections","volume":"91","author":"Hamdi","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb0695","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.3727\/096368912X638847","article-title":"Treatment of reperfused ischemia with adipose-derived stem cells in a preclinical swine model of myocardial infarction","volume":"21","author":"Mazo","year":"2012","journal-title":"Cell Transplant."},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb0700","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/term.46","article-title":"Myocardial tissue engineering: a review","volume":"1","author":"Jawad","year":"2007","journal-title":"J. Tissue Eng. Regen. Med."},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb0705","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00246-009-9405-6","article-title":"Cardiac tissue engineering: implications for pediatric heart surgery","volume":"30","author":"Zimmermann","year":"2009","journal-title":"Pediatr. Cardiol."},{"issue":"11","key":"10.1016\/j.lfs.2024.122858_bb0710","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.3727\/096368914X685780","article-title":"Adipose-derived stem cells from both visceral and subcutaneous fat deposits significantly improve contractile function of infarcted rat hearts","volume":"24","author":"Chi","year":"2015","journal-title":"Cell Transplant."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0715","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jss.2008.03.019","article-title":"Adipose tissue-derived cells improve cardiac function following myocardial infarction","volume":"153","author":"Schenke-Layland","year":"2009","journal-title":"J. Surg. Res."},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb0720","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005771","article-title":"Intracoronary Administration of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Improves Myocardial Perfusion but not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction","volume":"6","author":"Bobi","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0725","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/med.21839","article-title":"Combining stem cells in myocardial infarction: the road to superior repair?","volume":"42","author":"Beli\u00ebn","year":"2022","journal-title":"Med. Res. Rev."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0730","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0092-8674(02)01078-4","article-title":"Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury","volume":"111","author":"LaBarge","year":"2002","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0735","first-page":"479","article-title":"Stem cell treatment of the heart: a review of its current status on the brink of clinical experimentation","volume":"32","author":"Angelini","year":"2005","journal-title":"Tex. Heart Inst. J."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0740","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1152\/physrev.00013.2005","article-title":"Cardiac stem cells and mechanisms of myocardial regeneration","volume":"85","author":"Leri","year":"2005","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0745","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.RES.0000151843.79801.60","article-title":"Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion","volume":"96","author":"Kajstura","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2024.122858_bb0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.cellbio.19.111301.143037","article-title":"Adult stem cell plasticity: fact or artifact?","volume":"19","author":"Raff","year":"2003","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb0755","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0092-8674(04)00208-9","article-title":"Plasticity of adult stem cells","volume":"116","author":"Wagers","year":"2004","journal-title":"Cell"},{"issue":"6829","key":"10.1016\/j.lfs.2024.122858_bb0760","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","article-title":"Bone marrow cells regenerate infarcted myocardium","volume":"410","author":"Orlic","year":"2001","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.lfs.2024.122858_bb0765","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1161\/01.CIR.0000034046.87607.1C","article-title":"Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans","volume":"106","author":"Strauer","year":"2002","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.lfs.2024.122858_bb0770","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.RES.0000144798.54040.ed","article-title":"Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction","volume":"95","author":"Fern\u00e1ndez-Avil\u00e9s","year":"2004","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.lfs.2024.122858_bb0775","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jacc.2004.08.014","article-title":"Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial","volume":"44","author":"Sch\u00e4chinger","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11 Suppl 1","key":"10.1016\/j.lfs.2024.122858_bb0780","first-page":"Ii213","article-title":"Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy","volume":"110","author":"Perin","year":"2004","journal-title":"Circulation"},{"issue":"9411","key":"10.1016\/j.lfs.2024.122858_bb0785","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0140-6736(04)15689-4","volume":"363","author":"Kang","year":"2004","journal-title":"Lancet"},{"issue":"9429","key":"10.1016\/j.lfs.2024.122858_bb0790","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(04)16626-9","article-title":"Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial","volume":"364","author":"Wollert","year":"2004","journal-title":"Lancet"},{"issue":"9351","key":"10.1016\/j.lfs.2024.122858_bb0795","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(03)12110-1","article-title":"Autologous bone-marrow stem-cell transplantation for myocardial regeneration","volume":"361","author":"Stamm","year":"2003","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb0800","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jcyt.2017.08.004","article-title":"Umbilical cord mesenchymal stromal cell transplantations: a systemic analysis of clinical trials","volume":"19","author":"Can","year":"2017","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0805","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.4238\/2015.April.10.11","article-title":"Clinical observation of umbilical cord mesenchymal stem cell treatment of severe systolic heart failure","volume":"14","author":"Zhao","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0810","first-page":"100","article-title":"Myocardial regeneration strategy using Wharton\u2019s jelly mesenchymal stem cells as an off-the-shelf \u2018unlimited\u2019 therapeutic agent: results from the acute myocardial infarction first-in-man study","volume":"11","author":"Musialek","year":"2015","journal-title":"Postepy Kardiol Interwencyjnej"},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb0815","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3892\/etm.2016.3748","article-title":"Functional characterization of human umbilical cord-derived mesenchymal stem cells for treatment of systolic heart failure","volume":"12","author":"Fang","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0820","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.archger.2014.10.011","article-title":"Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"60","author":"Gao","year":"2015","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"11","key":"10.1016\/j.lfs.2024.122858_bb0825","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2174\/1381612821666141126100636","article-title":"Safety and efficacy of intracoronary human umbilical cord-derived mesenchymal stem cell treatment for very old patients with coronary chronic total occlusion","volume":"21","author":"Li","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0830","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s13287-022-02914-z","article-title":"Intramyocardial injected human umbilical cord-derived mesenchymal stem cells (HucMSCs) contribute to the recovery of cardiac function and the migration of CD4(+) T cells into the infarcted heart via CCL5\/CCR5 signaling","volume":"13","author":"Liu","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"10.1016\/j.lfs.2024.122858_bb0835","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.116.303614","article-title":"Use of mesenchymal stem cells for therapy of cardiac disease","volume":"116","author":"Karantalis","year":"2015","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.lfs.2024.122858_bb0840","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jcyt.2019.04.056","article-title":"Umbilical cord-derived mesenchymal stromal cells in cardiovascular disease: review of preclinical and clinical data","volume":"21","author":"Colicchia","year":"2019","journal-title":"Cytotherapy"},{"issue":"11","key":"10.1016\/j.lfs.2024.122858_bb0845","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1634\/stemcells.2007-0637","article-title":"Concise review: mesenchymal stem\/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views","volume":"25","author":"Phinney","year":"2007","journal-title":"Stem Cells"},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb0850","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115316","article-title":"Proangiogenic compositions of microvesicles derived from human umbilical cord mesenchymal stem cells","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0855","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009016","article-title":"Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially","volume":"5","author":"Prasanna","year":"2010","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb0860","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.bbmt.2007.08.048","article-title":"Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation","volume":"13","author":"Friedman","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0865","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12015-012-9418-z","article-title":"The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord","volume":"9","author":"Bongso","year":"2013","journal-title":"Stem Cell Rev. Rep."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0870","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/scrt477","article-title":"Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton's jelly derived mesenchymal stem cells? A comparative study","volume":"5","author":"Swamynathan","year":"2014","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0875","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.athoracsur.2006.10.066","article-title":"Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model","volume":"83","author":"Wu","year":"2007","journal-title":"Ann. Thorac. Surg."},{"issue":"10","key":"10.1016\/j.lfs.2024.122858_bb0880","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"121","author":"Bartolucci","year":"2017","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.lfs.2024.122858_bb0885","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00395-011-0221-9","article-title":"Mesenchymal stromal cells mediate a switch to alternatively activated monocytes\/macrophages after acute myocardial infarction","volume":"106","author":"Dayan","year":"2011","journal-title":"Basic Res. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0890","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/scrt394","article-title":"Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms","volume":"5","author":"Santos Nascimento","year":"2014","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"10.1016\/j.lfs.2024.122858_bb0895","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.5966\/sctm.2015-0298","article-title":"Human umbilical cord-derived mesenchymal stromal cells improve left ventricular function, perfusion, and remodeling in a porcine model of chronic myocardial ischemia","volume":"5","author":"Liu","year":"2016","journal-title":"Stem Cells Transl. Med."},{"issue":"8","key":"10.1016\/j.lfs.2024.122858_bb0900","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1634\/stemcells.2006-0662","article-title":"The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro","volume":"25","author":"Nishiyama","year":"2007","journal-title":"Stem Cells"},{"issue":"23","key":"10.1016\/j.lfs.2024.122858_bb0905","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1089\/scd.2013.0119","article-title":"Grafts enriched with subamnion-cord-lining mesenchymal stem cell angiogenic spheroids induce post-ischemic myocardial revascularization and preserve cardiac function in failing rat hearts","volume":"22","author":"Martinez","year":"2013","journal-title":"Stem Cells Dev."},{"issue":"7","key":"10.1016\/j.lfs.2024.122858_bb0910","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/MCA.0b013e3283640f00","article-title":"Wharton\u2019s jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction","volume":"24","author":"Zhang","year":"2013","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.lfs.2024.122858_bb0915","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12967-014-0253-7","article-title":"Clinical observation of umbilical cord mesenchymal stem cell transplantation in treatment for sequelae of thoracolumbar spinal cord injury","volume":"12","author":"Cheng","year":"2014","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.lfs.2024.122858_bb0920","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.5966\/sctm.2015-0022","article-title":"Chorion mesenchymal stem cells show superior differentiation, immunosuppressive, and Angiogenic potentials in comparison with Haploidentical maternal placental cells","volume":"4","author":"Gonz\u00e1lez","year":"2015","journal-title":"Stem Cells Transl. Med."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0925","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/01.CIR.0000151812.86142.45","article-title":"Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model","volume":"111","author":"Silva","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0930","first-page":"212","article-title":"Umbilical cord mesenchymal stem cell transplantation in the treatment of multiple sclerosis","volume":"10","author":"Meng","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"36","key":"10.1016\/j.lfs.2024.122858_bb0935","first-page":"3441","article-title":"Human umbilical cord mesenchymal stem cell-loaded amniotic membrane for the repair of radial nerve injury","volume":"8","author":"Li","year":"2013","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0940","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jcyt.2014.09.010","article-title":"Effect of umbilical cord mesenchymal stromal cells on motor functions of identical twins with cerebral palsy: pilot study on the correlation of efficacy and hereditary factors","volume":"17","author":"Wang","year":"2015","journal-title":"Cytotherapy"},{"issue":"7","key":"10.1016\/j.lfs.2024.122858_bb0945","first-page":"3241","article-title":"Therapeutic effects of human umbilical cord mesenchymal stem cells transplantation on hypoxic ischemic encephalopathy","volume":"8","author":"Xie","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"7","key":"10.1016\/j.lfs.2024.122858_bb0950","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehs381","article-title":"Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)","volume":"34","author":"F\u00fclster","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2024.122858_bb0955","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12872-016-0278-3","article-title":"Primary skeletal muscle myoblasts from chronic heart failure patients exhibit loss of anti-inflammatory and proliferative activity","volume":"16","author":"Sente","year":"2016","journal-title":"BMC Cardiovasc. Disord."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb0960","doi-asserted-by":"crossref","first-page":"187","DOI":"10.14797\/mdcj-9-4-187","article-title":"Stem cell therapy for heart failure","volume":"9","author":"Michler","year":"2013","journal-title":"Methodist Debakey Cardiovasc. J."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb0965","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1477-7827-1-101","article-title":"Skeletal muscle stem cells","volume":"1","author":"Chen","year":"2003","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.lfs.2024.122858_bb0970","first-page":"3294","article-title":"Myocardial regeneration with satellite cell implantation","volume":"26","author":"Zibaitis","year":"1994","journal-title":"Transplant. Proc."},{"issue":"6","key":"10.1016\/j.lfs.2024.122858_bb0975","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jtcvs.2006.07.023","article-title":"Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure","volume":"132","author":"Bonaros","year":"2006","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb0980","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.yjmcc.2006.09.011","article-title":"Stem cell therapy enhances electrical viability in myocardial infarction","volume":"42","author":"Mills","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"12 Suppl 1","key":"10.1016\/j.lfs.2024.122858_bb0985","doi-asserted-by":"crossref","first-page":"I213","DOI":"10.1161\/hc37t1.094929","article-title":"Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin-induced heart failure","volume":"104","author":"Suzuki","year":"2001","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb0990","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/01.CIR.0000142861.55862.15","article-title":"Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy?","volume":"110","author":"Pouly","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.lfs.2024.122858_bb0995","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/eurheartj\/ehp342","article-title":"Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction","volume":"31","author":"Gavira","year":"2010","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.lfs.2024.122858_bb1000","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003071","article-title":"Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat","volume":"3","author":"Fukushima","year":"2008","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb1005","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/eurheartj\/ehi159","article-title":"Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial","volume":"26","author":"Siminiak","year":"2005","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb1010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcin.2008.11.003","article-title":"One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study)","volume":"2","author":"Dib","year":"2009","journal-title":"JACC Cardiovasc. Interv."},{"issue":"9","key":"10.1016\/j.lfs.2024.122858_bb1015","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","article-title":"The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation","volume":"117","author":"Menasch\u00e9","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.lfs.2024.122858_bb1020","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.113.300219","article-title":"Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions","volume":"113","author":"Sanganalmath","year":"2013","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb1025","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ahj.2011.07.020","article-title":"A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction","volume":"162","author":"Povsic","year":"2011","journal-title":"Am. Heart J."},{"issue":"7","key":"10.1016\/j.lfs.2024.122858_bb1030","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0735-1097(03)00092-5","article-title":"Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction","volume":"41","author":"Menasch\u00e9","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.lfs.2024.122858_bb1035","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1161\/CIRCRESAHA.111.243154","article-title":"Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology","volume":"109","author":"Leri","year":"2011","journal-title":"Circ. Res."},{"issue":"7432","key":"10.1016\/j.lfs.2024.122858_bb1040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature11682","article-title":"Mammalian heart renewal by pre-existing cardiomyocytes","volume":"493","author":"Senyo","year":"2013","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.lfs.2024.122858_bb1045","doi-asserted-by":"crossref","first-page":"12313","DOI":"10.1073\/pnas.2132126100","article-title":"Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction","volume":"100","author":"Oh","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7026","key":"10.1016\/j.lfs.2024.122858_bb1050","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nature03215","article-title":"Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages","volume":"433","author":"Laugwitz","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2024.122858_bb1055","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3536854","article-title":"C-kit cardiac progenitor cell based cell sheet improves vascularization and attenuates cardiac remodeling following myocardial infarction in rats","volume":"2018","author":"Dergilev","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb1060","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ydbio.2003.09.028","article-title":"Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart","volume":"265","author":"Martin","year":"2004","journal-title":"Dev. Biol."},{"issue":"35","key":"10.1016\/j.lfs.2024.122858_bb1065","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1073\/pnas.0706760104","article-title":"Human cardiac stem cells","volume":"104","author":"Bearzi","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2024.122858_bb1070","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2217\/fca-2018-0049","article-title":"An overview of the myocardial regeneration potential of cardiac c-kit(+) progenitor cells via PI3K and MAPK signaling pathways","volume":"16","author":"Fathi","year":"2020","journal-title":"Futur. Cardiol."},{"issue":"9806","key":"10.1016\/j.lfs.2024.122858_bb1075","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(11)61590-0","article-title":"Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial","volume":"378","author":"Bolli","year":"2011","journal-title":"Lancet"},{"issue":"10176","key":"10.1016\/j.lfs.2024.122858_bb1080","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(19)30542-2","article-title":"Retraction\u2014cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial","volume":"393","author":"Lancet","year":"2019","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.lfs.2024.122858_bb1085","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/CIRCULATIONAHA.109.909093","article-title":"Cardiomyogenic potential of C-kit+\u2013expressing cells derived from neonatal and adult mouse hearts","volume":"121","author":"Zaruba","year":"2010","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb1090","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001260","article-title":"Relative roles of CD 90 and c-kit to the regenerative efficacy of Cardiosphere-derived cells in humans and in a mouse model of myocardial infarction","volume":"3","author":"Cheng","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.lfs.2024.122858_bb1095","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jtcvs.2008.05.019","article-title":"Cardiac stem cells in the real world","volume":"136","author":"Koninckx","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"9","key":"10.1016\/j.lfs.2024.122858_bb1100","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/01.RES.0000147315.71699.51","article-title":"Isolation and expansion of adult cardiac stem cells from human and murine heart","volume":"95","author":"Messina","year":"2004","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb1105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13287-017-0481-x","article-title":"Cardiosphere-derived cells do not improve cardiac function in rats with cardiac failure","volume":"8","author":"Kasai-Brunswick","year":"2017","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"10.1016\/j.lfs.2024.122858_bb1110","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/stem.72","article-title":"Murine \"cardiospheres\" are not a source of stem cells with cardiomyogenic potential","volume":"27","author":"Andersen","year":"2009","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.lfs.2024.122858_bb1115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/14653240701218516","article-title":"Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy","volume":"9","author":"Gentry","year":"2007","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb1120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488808786734006","article-title":"Aldehyde dehydrogenase as a marker for stem cells","volume":"3","author":"Moreb","year":"2008","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2024.122858_bb1125","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/cvr\/cvs427","article-title":"The cardiac atrial appendage stem cell: a new and promising candidate for myocardial repair","volume":"97","author":"Koninckx","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2024.122858_bb1130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijcard.2015.07.066","article-title":"Cardiac atrial appendage stem cells engraft and differentiate into cardiomyocytes in vivo: a new tool for cardiac repair after MI","volume":"201","author":"Fanton","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2024.122858_bb1135","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.yjmcc.2016.06.005","article-title":"Cardiac atrial appendage stem cells promote angiogenesis in vitro and in vivo","volume":"97","author":"Fanton","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2024.122858_bb1140","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6640893","article-title":"Thermosensitive Chitosan-<i>\u03b2<\/i>-Glycerophosphate Hydrogels as Targeted Drug Delivery Systems: An Overview on Preparation and Their Applications","volume":"2021","author":"Rahmanian-Devin","year":"2021","journal-title":"Advances in Pharmacological and Pharmaceutical Sciences"},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb1145","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1002\/iub.2396","article-title":"Circulating exosomal microRNAs as emerging non-invasive clinical biomarkers in heart failure: mega bio-roles of a nano bio-particle","volume":"72","author":"Zhou","year":"2020","journal-title":"IUBMB Life"},{"issue":"22","key":"10.1016\/j.lfs.2024.122858_bb1150","first-page":"7952","article-title":"Exosomal piRNA sequencing reveals differences between heart failure and healthy patients","volume":"22","author":"Yang","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2024.122858_bb1155","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCRESAHA.113.301209","article-title":"Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction","volume":"113","author":"Matsumoto","year":"2013","journal-title":"Circ. Res."},{"issue":"14","key":"10.1016\/j.lfs.2024.122858_bb1160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147514","article-title":"Exosomal microRNAs miR-30d-5p and miR-126a-5p are associated with heart failure with preserved ejection fraction in STZ-induced type 1 diabetic rats","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.lfs.2024.122858_bb1165","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.kjms.2018.05.008","article-title":"Reduced exosome miR-425 and miR-744 in the plasma represents the progression of fibrosis and heart failure","volume":"34","author":"Wang","year":"2018","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb1170","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1159\/000489383","article-title":"Serum Exosomal MiR-92b-5p as a potential biomarker for acute heart failure caused by dilated cardiomyopathy","volume":"46","author":"Wu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb1175","doi-asserted-by":"crossref","first-page":"324","DOI":"10.14715\/cmb\/2021.67.5.44","article-title":"Clinical significance of MiR-27a expression in serum exosomes in patients with heart failure","volume":"67","author":"Xie","year":"2022","journal-title":"Cell. Mol. Biol. (Noisy-le-Grand)"},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb1180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/eurjhf\/hfr155","article-title":"Serum levels of microRNAs in patients with heart failure","volume":"14","author":"Goren","year":"2012","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb1185","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1172\/JCI64365","article-title":"MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy","volume":"123","author":"Halkein","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb1190","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1186\/s13104-017-3090-y","article-title":"Inflammation-associated microRNA changes in circulating exosomes of heart failure patients","volume":"10","author":"Beg","year":"2017","journal-title":"BMC. Res. Notes"},{"key":"10.1016\/j.lfs.2024.122858_bb1195","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.yjmcc.2015.12.028","article-title":"Exosomes derived from dendritic cells improve cardiac function via activation of CD4(+) T lymphocytes after myocardial infarction","volume":"91","author":"Liu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb1200","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cvr\/cvu167","article-title":"Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction","volume":"103","author":"Barile","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.lfs.2024.122858_bb1205","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/cvr\/cvy055","article-title":"Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-a","volume":"114","author":"Barile","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"19","key":"10.1016\/j.lfs.2024.122858_bb1210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197215","article-title":"Cardiac fibroblast-induced pluripotent stem cell-derived exosomes as a potential therapeutic mean for heart failure","volume":"21","author":"Kurtzwald-Josefson","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.lfs.2024.122858_bb1215","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/CIRCULATIONAHA.112.114173","article-title":"Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension","volume":"126","author":"Lee","year":"2012","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb1220","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1536\/ihj.20-809","article-title":"Circ-SKA3 enhances doxorubicin toxicity in AC16 cells through miR-1303\/TLR4 Axis","volume":"62","author":"Li","year":"2021","journal-title":"Int. Heart J."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb1225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12951-020-00733-z","article-title":"Human trophoblast-derived exosomes attenuate doxorubicin-induced cardiac injury by regulating miR-200b and downstream Zeb1","volume":"18","author":"Ni","year":"2020","journal-title":"J Nanobiotechnology"},{"issue":"6","key":"10.1016\/j.lfs.2024.122858_bb1230","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1172\/JCI123135","article-title":"microRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential","volume":"129","author":"Qiao","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb1235","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00441-022-03663-4","article-title":"Effectiveness of exosome mediated miR-126 and miR-146a delivery on cardiac tissue regeneration","volume":"390","author":"Shafei","year":"2022","journal-title":"Cell Tissue Res."},{"issue":"11","key":"10.1016\/j.lfs.2024.122858_bb1240","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/cbin.11664","article-title":"Exosomal microRNA-1246 from human umbilical cord mesenchymal stem cells potentiates myocardial angiogenesis in chronic heart failure","volume":"45","author":"Wang","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.lfs.2024.122858_bb1245","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijcard.2014.10.144","article-title":"Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction","volume":"178","author":"Yamaguchi","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"10.1016\/j.lfs.2024.122858_bb1250","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s12012-022-09743-9","article-title":"Mesenchymal stem cell-derived exosome-loaded microRNA-129-5p inhibits TRAF3 expression to alleviate apoptosis and oxidative stress in heart failure","volume":"22","author":"Yan","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb1255","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2008.10.024","article-title":"Improvement of cardiac function and remodeling by transplanting adipose tissue-derived stromal cells into a mouse model of acute myocardial infarction","volume":"139","author":"Yu","year":"2010","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb1260","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.bbrc.2006.01.181","article-title":"Cardiac progenitor cells in brown adipose tissue repaired damaged myocardium","volume":"342","author":"Yamada","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.lfs.2024.122858_bb1265","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MCA.0b013e32801235da","article-title":"Adipose tissue stromal cells transplantation in rats of acute myocardial infarction","volume":"18","author":"Li","year":"2007","journal-title":"Coron. Artery Dis."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb1270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12013-011-9323-0","article-title":"Functional assessment of adipose stem cells for xenotransplantation using myocardial infarction immunocompetent models: comparison with bone marrow stem cells","volume":"67","author":"Paul","year":"2013","journal-title":"Cell Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb1275","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/jcmm.12036","article-title":"Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction","volume":"17","author":"Carvalho","year":"2013","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb1280","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3727\/096368912X659871","article-title":"Comparison of human adipose-derived stem cells and bone marrow-derived stem cells in a myocardial infarction model","volume":"23","author":"Rasmussen","year":"2014","journal-title":"Cell Transplant."},{"issue":"3","key":"10.1016\/j.lfs.2024.122858_bb1285","doi-asserted-by":"crossref","first-page":"H1020","DOI":"10.1152\/ajpheart.01082.2008","article-title":"Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts","volume":"297","author":"Wang","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"11","key":"10.1016\/j.lfs.2024.122858_bb1290","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.yexcr.2010.02.009","article-title":"Omentum-derived stromal cells improve myocardial regeneration in pig post-infarcted heart through a potent paracrine mechanism","volume":"316","author":"De Siena","year":"2010","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb1295","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/eci.12195","article-title":"Allogeneic adipose stem cell therapy in acute myocardial infarction","volume":"44","author":"Rigol","year":"2014","journal-title":"Eur. J. Clin. Investig."},{"issue":"22","key":"10.1016\/j.lfs.2024.122858_bb1300","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"Jama"},{"issue":"23","key":"10.1016\/j.lfs.2024.122858_bb1305","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","article-title":"Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics","volume":"61","author":"Bartunek","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.lfs.2024.122858_bb1310","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.114.303180","volume":"114","author":"Karantalis","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2024.122858_bb1315","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijcard.2016.02.016","article-title":"Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: results of the MESAMI 1 pilot trial","volume":"209","author":"Guijarro","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"27","key":"10.1016\/j.lfs.2024.122858_bb1320","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","article-title":"Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)","volume":"36","author":"Mathiasen","year":"2015","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb1325","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/ejhf.1700","article-title":"Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4-year follow-up of the MSC-HF trial","volume":"22","author":"Mathiasen","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"44","key":"10.1016\/j.lfs.2024.122858_bb1330","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1093\/eurheartj\/ehv390","article-title":"Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial","volume":"36","author":"Hamshere","year":"2015","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb1335","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/CIRCRESAHA.116.309717","article-title":"Intravenous allogeneic mesenchymal stem cells for nonischemic cardiomyopathy: safety and efficacy results of a phase II-A randomized trial","volume":"120","author":"Butler","year":"2017","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.lfs.2024.122858_bb1340","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2016.11.009","article-title":"Randomized comparison of allogeneic versus autologous mesenchymal stem cells for nonischemic dilated cardiomyopathy: POSEIDON-DCM trial","volume":"69","author":"Hare","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb1345","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1536\/ihj.16-328","article-title":"A randomized comparative study on the efficacy of intracoronary infusion of autologous bone marrow mononuclear cells and mesenchymal stem cells in patients with dilated cardiomyopathy","volume":"58","author":"Xiao","year":"2017","journal-title":"Int. Heart J."},{"key":"10.1016\/j.lfs.2024.122858_bb1350","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ahj.2018.02.009","article-title":"Rationale and design of the SENECA (StEm cell iNjECtion in cAncer survivors) trial","volume":"201","author":"Bolli","year":"2018","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb1355","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaccao.2020.09.001","article-title":"Allogeneic mesenchymal cell therapy in anthracycline-induced cardiomyopathy heart failure patients: the CCTRN SENECA trial","volume":"2","author":"Bolli","year":"2020","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.lfs.2024.122858_bb1360","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12916-015-0399-z","article-title":"Intracoronary infusion of Wharton\u2019s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial","volume":"13","author":"Gao","year":"2015","journal-title":"BMC Med."},{"issue":"1 Suppl","key":"10.1016\/j.lfs.2024.122858_bb1365","first-page":"I108","article-title":"Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients","volume":"114","author":"Hag\u00e8ge","year":"2006","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.lfs.2024.122858_bb1370","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4244\/EIJV6I7A139","article-title":"Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial","volume":"6","author":"Duckers","year":"2011","journal-title":"EuroIntervention"},{"issue":"12 Suppl 1","key":"10.1016\/j.lfs.2024.122858_bb1375","first-page":"I131","article-title":"Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction","volume":"106","author":"Ghostine","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb1380","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cardiores.2006.06.018","article-title":"A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction","volume":"71","author":"Gavira","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"14 Suppl","key":"10.1016\/j.lfs.2024.122858_bb1385","first-page":"S130","article-title":"Skeletal myoblasts preserve remote matrix architecture and global function when implanted early or late after coronary ligation into infarcted or remote myocardium","volume":"118","author":"Farahmand","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lfs.2024.122858_bb1390","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCRESAHA.108.178525","article-title":"Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function","volume":"103","author":"Rota","year":"2008","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.lfs.2024.122858_bb1395","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.108.816058","article-title":"Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy","volume":"120","author":"Johnston","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lfs.2024.122858_bb1400","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.109.871905","article-title":"Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction","volume":"121","author":"Tang","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.lfs.2024.122858_bb1405","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacc.2010.07.049","article-title":"Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction","volume":"57","author":"Lee","year":"2011","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052400448X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052400448X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T12:02:38Z","timestamp":1732276958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052400448X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":281,"alternative-id":["S002432052400448X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122858","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cell and exosome therapies for regenerating damaged myocardium in heart failure","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122858"}}